AOP Health: BESREMi®

BESREMi®

Ropeginterferon alfa-2b

BESREMi® is used as monotherapy for the treatment of polycythemia vera in adults. Polycythemia vera is a type of cancer in which the bone marrow produces too many red blood cells, white blood cells and platelets (cells that help the blood to clot).

BESREMi® contains the active substance ropeginterferon alfa-2b, which belongs to the class of medicines called interferons. Interferons are produced by your immune system to block the growth of cancer cells.

BESREMi® is presented as a solution for injection (injection) in a pre-filled pen.

back to products

Needs. Science. Trust.

As a privately owned company, AOP Health is devoted to long-term commitment, high quality, and continuity. For a small number of very special diseases the company is sole supplier of some key therapeutic agents throughout the world.